Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), relating to its proposed merger with GRI Bio, Inc. Under the terms of the agreement, VLON shareholders are expected to own approximately 17% of the combined company.
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), relating to its proposed merger with GRI Bio, Inc. Under the terms of the agreement, VLON shareholders are expected to own approximately 17% of the combined company.
Malvern Bancorp, Inc. (NASDAQ: MLVF), relating to its proposed acquisition by First Bank. Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own
The Community Financial Corp. (NASDAQ: TCFC), relating to its proposed merger with Shore Bancshares, Inc. Under the terms of the agreement, TCFC shareholders will receive 2.3287 shares of Shore common stock per share they own.
Horizon Therapeutics Public Limited Co. (NASDAQ: HZNP), relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, HZNP shareholders will receive $116.50 in cash per share they own.
Coupa Software Inc. (NASDAQ: COUP), relating to its proposed acquisition by Thoma Bravo and an investment from a subsidiary of the Abu Dhabi Investment Authority. Under the terms of the agreement, COUP shareholders will receive $81.00 in cash per share they own.
Weber Inc. (NYSE: WEBR), relating to its proposed acquisition by BDT Capital Partners LLC. Under the terms of the agreement, WEBR shareholders will receive $8.05 in cash per share they own.
PSB Holding Corp. (OTC: PSBP), relating to its proposed merger with Summit Financial Group, Inc. Under the terms of the agreement, PSPB shareholders will receive 1.2347 shares of Summit per share they own
Vivint Smart Home, Inc. (NYSE: VVNT), relating to its proposed acquisition by NRG Energy, Inc. Under the terms of the agreement, VVNT shareholders will receive $12.00 in cash per share they own.
Graybug Vision, Inc. (GRAY), relating to its proposed merger with CalciMedica Inc. Under the terms of the merger, GRAY shareholders will own approximately 29% of the combined company
Apollo Endosurgery, Inc. (APEN), relating to its proposed sale to Boston Scientific Corp. Under the terms of the merger, APEN shareholders will receive $10.00 in cash per share they own.